Marc A Beaghler, MD
Urology · Ventura
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 36 years
- Creighton University School of Medicine, 1990
Offices
1 location · Community Memorial Health System · 187 clinicians in this group
Looking this up.
Hospitals listed: Community Memorial Hospital - Ojai · Community Memorial Hospital - Ventura · St Johns Regional Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Beaghler’s office at (805) 643-4067 to ask if they take your plan before you enroll.
California Medical Board record
Licence G73931 · Current
Licensed to practise in California · since 1992 · expires 2027-12-31 · Creighton University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Community Memorial Hospital - OjaiOjai, CACritical Access Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Community Memorial Health System, which runs 2 hospitals82% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
- Community Memorial Hospital - VenturaVentura, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Community Memorial Health System, which runs 2 hospitalsPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.478, Oct 2024 – Sep 2025
- St Johns Regional Medical CenterOxnard, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 68% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.06 (90.32 to 169.81) · 120 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.404, Oct 2024 – Sep 2025
See every measure and the patient survey for Community Memorial Hospital - Ojai
Behind the star rating — Deaths: 0 better, 1 the same, 0 worse of 1 measures. Readmissions: 0 better, 1 the same, 0 worse of 1 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 28 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 74 cases | None | Jul 2024 – Jun 2025 |
| Clostridium Difficile (C.Diff)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -36.9 · 29 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17 · 31 cases | None | Jul 2023 – Jun 2025 |
| Room was "always" clean | 86% |
| Nurses "always" communicated well | 83% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 90% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 89% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 81% |
| Nurses "always" treated them with courtesy and respect | 93% |
| "Always" quiet at night | 51% |
| "YES", patients would definitely recommend the hospital | 82% |
| Staff "always" explained possible side effects | 52% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
See every measure and the patient survey for Community Memorial Hospital - Ventura
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 11 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.478 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0.06 to 1.95) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.82 (0.49 to 1.15) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.27 (93.9 to 200.65) · 66 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 47 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.8 · 86 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 120 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.6 · 273 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.8 · 363 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.1 · 275 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 3,592 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.36) · 5,727 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.1 to 0.49) · 5,976 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.6 (1.57 to 5.64) · 1,733 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.39 (0 to 2.97) · 688 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.97 (1.53 to 4.4) · 1,669 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.87 (1.2 to 14.54) · 661 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.98 (1.35 to 8.61) · 686 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.94 (0.47 to 3.41) · 327 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.19 (0 to 0.93) · 3,678 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3 · 218 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.548 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.157 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.228 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.373 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 249 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.8 · 649 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -0.8 · 157 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -40.6 · 357 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -5 · 407 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 619 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.4 to 8) · 109 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9 (6.1 to 13) · 109 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10 · 90 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 164 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.2 (8.7 to 14.7) · 1,178 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 986 cases | No different | Jan 2024 – Dec 2024 |
What patients said (949 patients answered, 21% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for St Johns Regional Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.06 (90.32 to 169.81) · 120 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.404 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.8 (0 to 1.75) · 1,494 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.56 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 40 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 8.7 · 279 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.1 · 580 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.6 · 654 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,404 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.37) · 8,124 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.39) · 8,331 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.92 (1.89 to 5.95) · 1,414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.17 (0.6 to 3.75) · 412 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.94 (0.46 to 3.43) · 1,361 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.75 (0.73 to 12.78) · 439 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.94 (3.39 to 10.49) · 383 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.94 (0.47 to 3.41) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.11 (0 to 0.67) · 7,172 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 88 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.236 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.331 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.571 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.737 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 336 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 715 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -8.1 · 284 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.6 · 648 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -9.1 · 674 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.9 · 670 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (5.2 to 8.9) · 428 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (8.6 to 13.5) · 428 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.9 · 98 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 196 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.5 to 18.8) · 247 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 486 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,151 patients answered, 18% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$113,031
Medicare paid this office $113,031 for 527 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 330 | $40,659 | $74 |
| New patient visit (45+ min) | 127 | $12,782 | $101 |
| Shock wave crushing of kidney stones | 19 | $9,713 | $486 |
| Short return visit (20+ min) | 167 | $9,535 | $48 |
| Diagnostic exam of bladder and urethra using an endoscope | 87 | $6,327 | $62 |
See all 18 services
| Return visit (30+ min) | 330 | $40,659 | $74 |
| New patient visit (45+ min) | 127 | $12,782 | $101 |
| Shock wave crushing of kidney stones | 19 | $9,713 | $486 |
| Short return visit (20+ min) | 167 | $9,535 | $48 |
| Diagnostic exam of bladder and urethra using an endoscope | 87 | $6,327 | $62 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $1,968 | $109 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 11 | $1,645 | $150 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 11 | $1,607 | $41 |
| Injection of biodegradable material next to prostate | 11 | $1,516 | $138 |
| Biopsy of prostate gland | 14 | $1,311 | $94 |
| Placement of device in prostate for radiation therapy | 17 | $916 | $54 |
| Ultrasound scan of pelvic region through rectum | 29 | $793 | $26 |
| Simple measurement of pressure of urine flow in bladder | 13 | $720 | $55 |
| Ultrasonic guidance for needle placement | 19 | $451 | $23 |
| Simple insertion of temporary bladder tube | 13 | $440 | $21 |
| Simple bladder irrigation and/or instillation | 14 | $376 | $24 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 15 | $118 | $7 |
| Electronic assessment of bladder emptying | 22 | $77 | $3 |
Procedures Medicare counted
| Melanoma (skin cancer) excision | 1-10 | None |
| Prostate resection | 17 | More than 74% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Diagnostic exam of bladder and urethra using an endoscope | 150 | 104 | 123 | 102 | 111 | 102 |
| Shock wave crushing of kidney stones | 27 | 35 | 24 | 28 | 28 | 20 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 54 | – | 58 | – | – | 39 |
| Electronic assessment of bladder emptying | 57 | 22 | 18 | – | 20 | 23 |
| Placement of device in prostate for radiation therapy | – | 20 | 11 | 28 | 22 | 17 |
| Injection of biodegradable material next to prostate | – | 21 | 11 | 23 | 16 | 11 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
527 Original Medicare patients in 2024. Average age 76 · Under 65 3% · 85 and older 17% · Women 18% · Also on Medicaid 19% · Health risk score 1.42. Above the middle of the specialty; the typical urology clinician is at 1.36.
Conditions among them: High blood pressure 75% · Chronic kidney disease 33% · Diabetes 32% · Cancer 31% · Coronary heart disease 29% · Atrial fibrillation 28% · Depression 23% · Heart failure 20% · COPD 15% · Stroke 12% · Dementia 9%.
The office billed $405,095, Medicare allowed $151,264 and paid $113,031; for 1,386 services of 55 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 527 | 1,386 | 76 | 1.42 | $405,095 | $113,031 |
| 2023 | 560 | 1,449 | 76 | 1.22 | $469,708 | $122,994 |
| 2022 | 548 | 1,456 | 76 | 1.23 | $465,505 | $124,916 |
| 2021 | 537 | 1,467 | 76 | 1.36 | $511,598 | $128,261 |
| 2020 | 547 | 1,479 | 75 | 1.48 | $594,644 | $117,464 |
| 2019 | 636 | 2,017 | 75 | 1.49 | $656,669 | $155,927 |
| 2018 | 641 | 1,789 | 75 | 1.40 | $523,607 | $133,316 |
| 2017 | 680 | 2,131 | 75 | 1.39 | $563,546 | $151,373 |
| 2016 | 603 | 2,057 | 74 | 1.42 | $527,323 | $154,240 |
| 2015 | 600 | 1,961 | 75 | 1.41 | $525,370 | $151,667 |
| 2014 | 629 | 1,966 | 75 | 1.36 | $629,402 | $178,346 |
| 2013 | 633 | 2,145 | 75 | 1.47 | $649,911 | $174,746 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Return visit (30+ min) | 307 | $34,182 | $74 |
| Short return visit (20+ min) | 230 | $14,111 | $49 |
| Shock wave crushing of kidney stones | 27 | $13,349 | $477 |
| New patient visit (45+ min) | 132 | $13,278 | $101 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 13 | $7,971 | $613 |
| Diagnostic exam of bladder and urethra using an endoscope | 92 | $6,638 | $60 |
| Crushing of stone of ureter with insertion of stent using an endoscope | 14 | $4,105 | $293 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $2,923 | $104 |
| Injection of biodegradable material next to prostate | 16 | $2,214 | $138 |
| Biopsy of prostate gland | 13 | $1,196 | $92 |
| Placement of device in prostate for radiation therapy | 21 | $1,106 | $50 |
| Ultrasound scan of pelvic region through rectum | 32 | $930 | $27 |
| Ultrasonic guidance for needle placement | 19 | $460 | $24 |
| Imaging of urinary tract following injection of a contrast agent | 16 | $372 | $21 |
| Short return visit | 13 | $356 | $27 |
| Electronic assessment of bladder emptying | 20 | $70 | $4 |
2022: 14 services
| Return visit (30+ min) | 296 | $37,426 | $75 |
| Short return visit (20+ min) | 241 | $15,627 | $49 |
| Shock wave crushing of kidney stones | 24 | $13,783 | $492 |
| New patient visit (45+ min) | 134 | $12,895 | $96 |
| Diagnostic exam of bladder and urethra using an endoscope | 87 | $6,426 | $63 |
| Injection of biodegradable material next to prostate | 23 | $3,185 | $138 |
| Biopsy of prostate gland | 17 | $1,563 | $92 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 18 | $1,495 | $83 |
| Placement of device in prostate for radiation therapy | 28 | $1,419 | $51 |
| Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | 11 | $1,159 | $105 |
| Ultrasound scan of pelvic region through rectum | 28 | $769 | $26 |
| Ultrasonic guidance for needle placement | 22 | $540 | $23 |
| Imaging of urinary tract following injection of a contrast agent | 14 | $332 | $20 |
| Short return visit | 12 | $218 | $18 |
2021: 14 services
| Return visit (30+ min) | 278 | $33,027 | $78 |
| New patient visit (45+ min) | 162 | $17,049 | $105 |
| Short return visit (20+ min) | 233 | $16,711 | $51 |
| Shock wave crushing of kidney stones | 22 | $11,635 | $485 |
| Diagnostic exam of bladder and urethra using an endoscope | 105 | $7,968 | $65 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 16 | $2,572 | $161 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 16 | $2,314 | $40 |
| Injection of biodegradable material next to prostate | 11 | $1,477 | $134 |
| Insertion of stent in ureter using an endoscope | 13 | $1,379 | $106 |
| Telephone medical discussion with physician, 11-20 minutes | 27 | $1,267 | $41 |
| Telephone medical discussion with physician, 21-30 minutes | 13 | $1,127 | $80 |
| Simple measurement of pressure of urine flow in bladder | 13 | $709 | $55 |
| Placement of device in prostate for radiation therapy | 11 | $476 | $43 |
| Electronic assessment of bladder emptying | 18 | $65 | $4 |
2020: 16 services
| Return visit (30+ min) | 270 | $25,475 | $62 |
| Shock wave crushing of kidney stones | 34 | $17,355 | $496 |
| New patient visit (45+ min) | 123 | $11,362 | $92 |
| Short return visit (20+ min) | 208 | $10,303 | $37 |
| Diagnostic exam of bladder and urethra using an endoscope | 88 | $6,611 | $64 |
| Telephone medical discussion with physician, 11-20 minutes | 77 | $3,420 | $41 |
| Injection of biodegradable material next to prostate | 21 | $3,035 | $145 |
| Simple change of bladder tube | 11 | $1,401 | $44 |
| Return visit (30+ min) | 15 | $997 | $62 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $897 | $60 |
| Placement of device in prostate for radiation therapy | 20 | $885 | $44 |
| Imaging of urinary tract following injection of a contrast agent | 20 | $437 | $22 |
| Ultrasonic guidance for needle placement | 11 | $283 | $26 |
| Ultrasound scan of pelvic region through rectum | 11 | $260 | $24 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 14 | $115 | $8 |
| Electronic assessment of bladder emptying | 22 | $71 | $3 |
2019: 18 services
| Return visit (30+ min) | 313 | $31,071 | $59 |
| Short return visit (20+ min) | 352 | $21,141 | $37 |
| New patient visit (45+ min) | 184 | $18,282 | $99 |
| Shock wave crushing of kidney stones | 24 | $13,265 | $491 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 16 | $10,070 | $629 |
| Diagnostic exam of bladder and urethra using an endoscope | 130 | $9,709 | $65 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 15 | $2,780 | $51 |
| Insertion of stent in ureter using an endoscope | 17 | $2,682 | $141 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 15 | $2,620 | $175 |
| Dilation of urethra using an endoscope | 16 | $2,619 | $125 |
| Biopsy of prostate gland | 19 | $1,899 | $100 |
| Ultrasound scan of pelvic region through rectum | 19 | $515 | $26 |
| Ultrasonic guidance for needle placement | 17 | $477 | $27 |
| Simple insertion of temporary bladder tube | 11 | $432 | $22 |
| Limited ultrasound scan behind abdominal cavity | 21 | $417 | $19 |
| Imaging of urinary tract following injection of a contrast agent | 14 | $329 | $22 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 20 | $241 | $8 |
| Electronic assessment of bladder emptying | 57 | $193 | $3 |
2018: 14 services
| Return visit (30+ min) | 312 | $30,684 | $61 |
| Short return visit (20+ min) | 318 | $17,093 | $37 |
| New patient visit (45+ min) | 146 | $14,312 | $98 |
| Shock wave crushing of kidney stones | 17 | $10,204 | $486 |
| Diagnostic exam of bladder and urethra using an endoscope | 118 | $8,820 | $63 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 19 | $3,423 | $51 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 19 | $3,172 | $167 |
| New patient visit (30+ min) | 49 | $2,680 | $55 |
| Dilation of urethra using an endoscope | 12 | $1,665 | $111 |
| Biopsy of prostate gland | 15 | $1,368 | $91 |
| Limited ultrasound scan behind abdominal cavity | 30 | $753 | $23 |
| Ultrasound scan of pelvic region through rectum | 21 | $527 | $25 |
| Ultrasonic guidance for needle placement | 15 | $401 | $27 |
| Electronic assessment of bladder emptying | 59 | $205 | $3 |
2017: 20 services
| Return visit (30+ min) | 316 | $31,117 | $59 |
| Short return visit (20+ min) | 367 | $20,475 | $36 |
| Diagnostic exam of bladder and urethra using an endoscope | 164 | $14,720 | $82 |
| New patient visit (45+ min) | 143 | $13,576 | $95 |
| Shock wave crushing of kidney stones | 24 | $11,380 | $474 |
| New patient visit (30+ min) | 90 | $5,100 | $57 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 21 | $3,738 | $178 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 21 | $3,187 | $50 |
| Biopsy of prostate gland | 27 | $2,816 | $104 |
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 12 | $2,155 | $180 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $1,805 | $100 |
| Insertion of stent in ureter using an endoscope | 11 | $1,621 | $125 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,086 | $54 |
| Limited ultrasound scan behind abdominal cavity | 38 | $991 | $22 |
| Ultrasound scan of pelvic region through rectum | 30 | $907 | $26 |
| Simple measurement of pressure of urine flow in bladder | 13 | $906 | $57 |
| Ultrasonic guidance for needle placement | 29 | $840 | $25 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 12 | $532 | $44 |
| Electronic assessment of bladder emptying | 67 | $252 | $4 |
| Imaging of urinary tract following injection of a contrast agent | 13 | $217 | $14 |
2016: 21 services
| Short return visit (20+ min) | 352 | $24,592 | $40 |
| Return visit (30+ min) | 251 | $24,454 | $63 |
| Diagnostic exam of bladder and urethra using an endoscope | 139 | $16,738 | $107 |
| New patient visit (45+ min) | 160 | $16,185 | $101 |
| Shock wave crushing of kidney stones | 17 | $9,264 | $488 |
| Complete laser vaporization of prostate including control of bleeding using an endoscope | 15 | $8,892 | $593 |
| Insertion of implant in urethra within prostate gland using an endoscope, 1 implant | 17 | $3,277 | $193 |
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 15 | $2,933 | $196 |
| Insertion of implant in urethra within prostate gland using an endoscope, each additional implant | 17 | $2,823 | $51 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 20 | $2,297 | $115 |
| Simple measurement of pressure of urine flow in bladder | 24 | $1,655 | $64 |
| Return visit (30+ min) | 47 | $1,322 | $25 |
| New patient visit (30+ min) | 23 | $1,321 | $57 |
| Diagnostic exam of bladder and urethra using an endoscope | 16 | $1,163 | $73 |
| Short return visit (20+ min) | 60 | $905 | $14 |
| Limited ultrasound scan behind abdominal cavity | 31 | $904 | $23 |
| New patient visit (45+ min) | 13 | $758 | $58 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 14 | $640 | $46 |
| Ultrasound scan of pelvic region through rectum | 13 | $454 | $28 |
| Ultrasonic guidance for needle placement | 11 | $367 | $28 |
| Electronic assessment of bladder emptying | 69 | $364 | $4 |
2015: 17 services
| Return visit (30+ min) | 297 | $31,478 | $58 |
| Short return visit (20+ min) | 300 | $18,229 | $39 |
| Diagnostic exam of bladder and urethra using an endoscope | 147 | $18,000 | $103 |
| New patient visit (45+ min) | 144 | $13,209 | $92 |
| Complete laser vaporization of prostate including control of bleeding using an endoscope | 17 | $10,064 | $592 |
| Biopsy of prostate gland | 20 | $2,219 | $111 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,077 | $115 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 22 | $1,856 | $84 |
| Simple measurement of pressure of urine flow in bladder | 23 | $1,598 | $64 |
| Dilation of urethra using an endoscope | 11 | $1,492 | $124 |
| New patient visit (30+ min) | 18 | $982 | $55 |
| Ultrasound scan of pelvic region through rectum | 28 | $965 | $28 |
| Limited ultrasound scan behind abdominal cavity | 33 | $945 | $22 |
| Ultrasonic guidance for needle placement | 25 | $838 | $28 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $721 | $33 |
| Simple insertion of temporary bladder tube | 13 | $441 | $21 |
| Electronic assessment of bladder emptying | 69 | $297 | $4 |
2014: 18 services
| Return visit (30+ min) | 300 | $32,092 | $60 |
| Short return visit (20+ min) | 302 | $17,568 | $37 |
| New patient visit (45+ min) | 186 | $17,521 | $94 |
| Diagnostic exam of bladder and urethra using an endoscope | 146 | $17,521 | $101 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 21 | $14,928 | $711 |
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 15 | $13,258 | $884 |
| Shock wave crushing of kidney stones | 16 | $8,066 | $474 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 21 | $2,519 | $114 |
| Insertion of stent in ureter using an endoscope | 12 | $2,213 | $138 |
| Biopsy of prostate gland | 18 | $1,893 | $105 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,097 | $84 |
| Ultrasonic guidance for needle placement | 31 | $895 | $28 |
| New patient visit (30+ min) | 14 | $889 | $64 |
| Ultrasound scan of pelvic region through rectum | 25 | $741 | $27 |
| Limited ultrasound scan behind abdominal cavity | 25 | $708 | $24 |
| Simple insertion of temporary bladder tube | 11 | $504 | $25 |
| Complete ultrasound scan behind abdominal cavity | 17 | $488 | $24 |
| Electronic assessment of bladder emptying | 55 | $213 | $4 |
2013: 21 services
| Return visit (30+ min) | 339 | $36,387 | $59 |
| Short return visit (20+ min) | 306 | $17,500 | $36 |
| Diagnostic exam of bladder and urethra using an endoscope | 153 | $16,048 | $96 |
| New patient visit (45+ min) | 167 | $15,800 | $95 |
| Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | 18 | $12,384 | $688 |
| Surgical removal of prostate and surrounding lymph nodes using an endoscope | 16 | $10,714 | $670 |
| Insertion of sacral nerve neurostimulator electrode | 11 | $6,029 | $548 |
| Destruction of prostate tissue using microwave induced heat | 12 | $5,922 | $493 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 36 | $3,738 | $104 |
| Insertion of stent in ureter using an endoscope | 18 | $2,976 | $106 |
| Biopsy of prostate gland | 24 | $2,487 | $104 |
| Complete ultrasound scan behind abdominal cavity | 50 | $1,802 | $27 |
| Insertion or replacement of peripheral, sacral, or gastric neurostimulator generator or receiver | 12 | $1,360 | $113 |
| Biopsy of bladder using an endoscope | 16 | $1,303 | $81 |
| Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | 14 | $1,156 | $64 |
| Ultrasonic guidance for needle placement | 38 | $996 | $26 |
| Removal of lymph nodes of both sides of pelvis using an endoscope | 11 | $884 | $80 |
| Ultrasound scan of pelvic region through rectum | 28 | $708 | $25 |
| New patient visit (30+ min) | 11 | $685 | $62 |
| Electronic assessment of bladder emptying | 75 | $303 | $4 |
| Imaging of urinary tract following injection of a contrast agent | 16 | $260 | $14 |
Medicaid work
$2,357 in 2024
Medicaid paid $2,357 for 52 billed services this clinician did in 2024, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 52 | $2,357 |
| 2024 | 52 | 1 | 19 | $2,357 |
| 2023 | 137 | 2 | 18 | $6,980 |
| 2021 | 78 | 2 | 20 | $4,031 |
| 2020 | 76 | 1 | 15 | $4,233 |
| 2019 | 58 | 2 | 15 | $2,779 |
| 2018 | 145 | 3 | 19 | $4,492 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 109 | $4,729 |
| New patient visit (45+ min) | 28 | $2,251 |
2021
| Return visit (30+ min) | 49 | $2,884 |
| Short return visit (20+ min) | 29 | $1,147 |
2020
| Return visit (30+ min) | 76 | $4,233 |
2019
| Return visit (30+ min) | 28 | $1,513 |
| Short return visit (20+ min) | 30 | $1,266 |
2018
| Return visit (30+ min) | 66 | $2,399 |
| Short return visit (20+ min) | 67 | $1,191 |
| New patient visit (45+ min) | 12 | $903 |
Drugs they prescribed that Part D paid
$243,721
Pharmacies billed $243,721 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (15 of 1,716) in 2024. At or below the middle of the specialty; the typical urology clinician is at 2%.
1,545 generic and fewer than 11 brand-name prescriptions · $243,721 in drug cost · 179 antibiotic prescriptions to 123 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Myrbetriq | 119 | $114,208 | $960 |
| Gemtesa | 39 | $44,201 | $1,133 |
| Mirabegron Er | 30 | $16,107 | $537 |
| Testosterone | 60 | $13,406 | $223 |
| Tamsulosin | 640 | $7,741 | $12 |
See all 19 drugs
| Myrbetriq | 119 | $114,208 | $960 |
| Gemtesa | 39 | $44,201 | $1,133 |
| Mirabegron Er | 30 | $16,107 | $537 |
| Testosterone | 60 | $13,406 | $223 |
| Tamsulosin | 640 | $7,741 | $12 |
| Potassium Citrate Er | 48 | $5,179 | $108 |
| Bicalutamide | 115 | $4,469 | $39 |
| Estradiol | 67 | $3,362 | $50 |
| Tadalafil | 54 | $3,288 | $61 |
| Tolterodine Tartrate Er | 37 | $2,733 | $74 |
| Solifenacin | 31 | $1,178 | $38 |
| Finasteride | 101 | $1,014 | $10 |
| Nitrofurantoin | 18 | $519 | $29 |
| Sulfamethoxazole-Trimethoprim | 41 | $464 | $11 |
| Dutasteride | 23 | $413 | $18 |
| Oxybutynin Chloride Er | 15 | $331 | $22 |
| Ciprofloxacin | 86 | $293 | $3 |
| Oxybutynin Chloride | 24 | $208 | $9 |
| Cephalexin | 15 | $112 | $7 |
Year by year
| 2024 | 1,716 | 520 | 1% (15) | None | $243,721 |
| 2023 | 1,515 | 440 | 1% (16) | None | $350,500 |
| 2022 | 1,483 | 462 | None | None | $205,838 |
| 2021 | 1,435 | 473 | None | 22% | $233,561 |
| 2020 | 1,673 | 468 | 3% (44) | 19% | $236,686 |
| 2019 | 1,404 | 395 | 2% (22) | None | $251,383 |
| 2018 | 1,229 | 364 | 2% (23) | None | $187,825 |
| 2017 | 1,337 | 402 | 3% (38) | None | $179,979 |
| 2016 | 1,133 | 358 | 3% (35) | None | $132,820 |
| 2015 | 1,008 | 330 | 4% (39) | None | $91,205 |
| 2014 | 956 | 297 | 7% (67) | None | $71,947 |
| 2013 | 853 | 255 | 6% (51) | None | $62,311 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 20 drugs
| Myrbetriq | 178 | $153,027 | $860 |
| Gemtesa | 43 | $45,879 | $1,067 |
| Tamsulosin | 521 | $9,982 | $19 |
| Testosterone | 49 | $7,905 | $161 |
| Potassium Citrate Er | 41 | $6,381 | $156 |
| Estradiol | 57 | $5,247 | $92 |
| Bicalutamide | 98 | $4,630 | $47 |
| Solifenacin | 35 | $2,456 | $70 |
| Finasteride | 122 | $2,391 | $20 |
| Dutasteride | 20 | $1,345 | $67 |
| Tolterodine Tartrate Er | 13 | $1,218 | $94 |
| Tadalafil | 42 | $1,170 | $28 |
| Nitrofurantoin Mono-Macro | 22 | $753 | $34 |
| Sildenafil Citrate | 19 | $625 | $33 |
| Oxybutynin Chloride | 26 | $584 | $22 |
| Sulfamethoxazole-Trimethoprim | 29 | $413 | $14 |
| Terazosin | 11 | $283 | $26 |
| Cephalexin | 21 | $245 | $12 |
| Ciprofloxacin | 45 | $188 | $4 |
| Alfuzosin Hcl Er | 12 | $187 | $16 |
2022: 22 drugs
| Myrbetriq | 183 | $138,101 | $755 |
| Gemtesa | 22 | $14,856 | $675 |
| Tamsulosin | 533 | $7,710 | $14 |
| Estradiol | 64 | $6,473 | $101 |
| Testosterone | 23 | $5,154 | $224 |
| Tolterodine Tartrate Er | 11 | $4,096 | $372 |
| Dutasteride | 37 | $3,764 | $102 |
| Potassium Citrate Er | 27 | $3,075 | $114 |
| Bicalutamide | 73 | $2,605 | $36 |
| Nitrofurantoin Mono-Macro | 28 | $1,761 | $63 |
| Finasteride | 115 | $1,706 | $15 |
| Oxybutynin Chloride Er | 19 | $1,077 | $57 |
| Nitrofurantoin | 21 | $993 | $47 |
| Solifenacin | 20 | $653 | $33 |
| Oxybutynin Chloride | 21 | $487 | $23 |
| Alfuzosin Hcl Er | 13 | $396 | $30 |
| Terazosin | 13 | $378 | $29 |
| Tadalafil | 27 | $309 | $11 |
| Ciprofloxacin | 70 | $304 | $4 |
| Sildenafil Citrate | 18 | $249 | $14 |
| Sulfamethoxazole-Trimethoprim | 18 | $236 | $13 |
| Cephalexin | 17 | $202 | $12 |
2021: 17 drugs
| Myrbetriq | 268 | $168,056 | $627 |
| Toviaz | 15 | $10,076 | $672 |
| Estradiol | 64 | $7,727 | $121 |
| Testosterone | 28 | $7,039 | $251 |
| Tamsulosin | 512 | $6,100 | $12 |
| Bicalutamide | 85 | $2,820 | $33 |
| Dutasteride | 27 | $1,924 | $71 |
| Finasteride | 72 | $1,220 | $17 |
| Nitrofurantoin Mono-Macro | 22 | $1,126 | $51 |
| Solifenacin | 41 | $965 | $24 |
| Oxybutynin Chloride Er | 13 | $627 | $48 |
| Alfuzosin Hcl Er | 13 | $572 | $44 |
| Nitrofurantoin | 16 | $492 | $31 |
| Ciprofloxacin | 71 | $290 | $4 |
| Cephalexin | 15 | $212 | $14 |
| Sulfamethoxazole-Trimethoprim | 15 | $165 | $11 |
| Sildenafil Citrate | 11 | $137 | $12 |
2020: 17 drugs
| Myrbetriq | 249 | $148,276 | $595 |
| Tamsulosin | 585 | $6,631 | $11 |
| Estradiol | 42 | $5,931 | $141 |
| Premarin | 14 | $5,508 | $393 |
| Bicalutamide | 94 | $3,117 | $33 |
| Solifenacin | 42 | $2,417 | $58 |
| Dutasteride | 34 | $2,269 | $67 |
| Finasteride | 93 | $1,484 | $16 |
| Nitrofurantoin Mono-Macro | 24 | $1,088 | $45 |
| Nitrofurantoin | 27 | $804 | $30 |
| Oxybutynin Chloride Er | 22 | $744 | $34 |
| Oxybutynin Chloride | 12 | $462 | $39 |
| Ciprofloxacin | 128 | $459 | $4 |
| Sulfamethoxazole-Trimethoprim | 30 | $438 | $15 |
| Cephalexin | 32 | $354 | $11 |
| Alendronate | 36 | $257 | $7 |
| Hydrocodone-Acetaminophen | 34 | $158 | $5 |
2019: 18 drugs
| Myrbetriq | 195 | $126,316 | $648 |
| Tamsulosin | 504 | $6,654 | $13 |
| Potassium Citrate Er | 14 | $2,718 | $194 |
| Bicalutamide | 85 | $2,152 | $25 |
| Trospium Chloride Er | 11 | $1,889 | $172 |
| Finasteride | 110 | $1,791 | $16 |
| Dutasteride | 38 | $1,653 | $44 |
| Trospium Chloride | 25 | $1,071 | $43 |
| Nitrofurantoin | 32 | $853 | $27 |
| Nitrofurantoin Mono-Macro | 16 | $657 | $41 |
| Oxybutynin Chloride | 14 | $617 | $44 |
| Ciprofloxacin | 102 | $500 | $5 |
| Oxybutynin Chloride Er | 15 | $353 | $24 |
| Sulfamethoxazole-Trimethoprim | 31 | $326 | $11 |
| Alendronate | 27 | $174 | $6 |
| Nystatin | 12 | $158 | $13 |
| Cephalexin | 16 | $151 | $9 |
| Hydrocodone-Acetaminophen | 21 | $128 | $6 |
2018: 18 drugs
| Myrbetriq | 182 | $112,661 | $619 |
| Androgel | 13 | $8,428 | $648 |
| Tamsulosin | 421 | $7,106 | $17 |
| Dutasteride | 41 | $4,215 | $103 |
| Estradiol | 14 | $3,430 | $245 |
| Trospium Chloride Er | 14 | $2,867 | $205 |
| Tolterodine Tartrate Er | 14 | $1,844 | $132 |
| Finasteride | 88 | $1,735 | $20 |
| Trospium Chloride | 26 | $1,592 | $61 |
| Bicalutamide | 57 | $1,386 | $24 |
| Nitrofurantoin Mono-Macro | 24 | $1,256 | $52 |
| Nitrofurantoin | 19 | $735 | $39 |
| Oxybutynin Chloride Er | 18 | $601 | $33 |
| Oxybutynin Chloride | 17 | $600 | $35 |
| Ciprofloxacin | 82 | $431 | $5 |
| Sulfamethoxazole-Trimethoprim | 31 | $335 | $11 |
| Cephalexin | 21 | $324 | $15 |
| Hydrocodone-Acetaminophen | 18 | $100 | $6 |
2017: 19 drugs
| Myrbetriq | 212 | $96,855 | $457 |
| Vesicare | 28 | $15,481 | $553 |
| Premarin | 22 | $8,129 | $369 |
| Tamsulosin | 355 | $7,383 | $21 |
| Cialis | 11 | $4,954 | $450 |
| Dutasteride | 51 | $4,552 | $89 |
| Trospium Chloride Er | 19 | $3,301 | $174 |
| Finasteride | 103 | $2,802 | $27 |
| Trospium Chloride | 30 | $2,702 | $90 |
| Bicalutamide | 102 | $2,416 | $24 |
| Testosterone | 15 | $2,024 | $135 |
| Oxybutynin Chloride Er | 22 | $990 | $45 |
| Nitrofurantoin | 16 | $907 | $57 |
| Oxybutynin Chloride | 18 | $881 | $49 |
| Nitrofurantoin Mono-Macro | 15 | $727 | $48 |
| Ciprofloxacin | 135 | $691 | $5 |
| Terazosin | 13 | $286 | $22 |
| Hydrocodone-Acetaminophen | 34 | $280 | $8 |
| Sulfamethoxazole-Trimethoprim | 21 | $222 | $11 |
2016: 19 drugs
| Myrbetriq | 101 | $43,880 | $434 |
| Vesicare | 41 | $25,206 | $615 |
| Tamsulosin | 330 | $8,211 | $25 |
| Premarin | 19 | $5,812 | $306 |
| Cialis | 13 | $5,270 | $405 |
| Estrace | 13 | $3,778 | $291 |
| Nitrofurantoin Mono-Macro | 28 | $2,482 | $89 |
| Trospium Chloride | 42 | $2,285 | $54 |
| Finasteride | 106 | $2,022 | $19 |
| Dutasteride-Tamsulosin | 17 | $1,851 | $109 |
| Dutasteride | 26 | $1,844 | $71 |
| Bicalutamide | 58 | $1,690 | $29 |
| Oxybutynin Chloride Er | 15 | $1,020 | $68 |
| Oxybutynin Chloride | 29 | $916 | $32 |
| Nitrofurantoin | 11 | $729 | $66 |
| Ciprofloxacin | 115 | $567 | $5 |
| Hydrocodone-Acetaminophen | 32 | $334 | $10 |
| Sulfamethoxazole-Trimethoprim | 14 | $155 | $11 |
| Cephalexin | 13 | $107 | $8 |
2015: 20 drugs
| Vesicare | 36 | $16,896 | $469 |
| Toviaz | 30 | $9,948 | $332 |
| Tamsulosin | 284 | $9,921 | $35 |
| Myrbetriq | 26 | $9,758 | $375 |
| Premarin | 17 | $4,157 | $245 |
| Jalyn | 15 | $2,467 | $164 |
| Bicalutamide | 76 | $2,453 | $32 |
| Finasteride | 89 | $2,086 | $23 |
| Avodart | 11 | $1,605 | $146 |
| Potassium Citrate Er | 11 | $1,519 | $138 |
| Methenamine Hippurate | 17 | $1,475 | $87 |
| Oxybutynin Chloride Er | 22 | $1,430 | $65 |
| Trospium Chloride | 24 | $1,207 | $50 |
| Nitrofurantoin | 22 | $1,152 | $52 |
| Nitrofurantoin Mono-Macro | 13 | $699 | $54 |
| Ciprofloxacin | 111 | $688 | $6 |
| Cephalexin | 32 | $606 | $19 |
| Doxazosin Mesylate | 14 | $553 | $39 |
| Hydrocodone-Acetaminophen | 37 | $475 | $13 |
| Sulfamethoxazole-Trimethoprim | 20 | $327 | $16 |
2014: 18 drugs
| Vesicare | 27 | $12,333 | $457 |
| Tamsulosin | 223 | $5,936 | $27 |
| Avodart | 28 | $5,450 | $195 |
| Toviaz | 17 | $4,280 | $252 |
| Jalyn | 21 | $3,816 | $182 |
| Oxybutynin Chloride Er | 59 | $3,525 | $60 |
| Cialis | 20 | $3,438 | $172 |
| Premarin | 15 | $2,907 | $194 |
| Nitrofurantoin Mono-Macro | 23 | $2,536 | $110 |
| Potassium Citrate Er | 15 | $2,445 | $163 |
| Bicalutamide | 51 | $2,005 | $39 |
| Finasteride | 74 | $1,914 | $26 |
| Nitrofurantoin | 12 | $1,132 | $94 |
| Ciprofloxacin | 106 | $816 | $8 |
| Hydrocodone-Acetaminophen | 57 | $798 | $14 |
| Sulfamethoxazole-Trimethoprim | 34 | $486 | $14 |
| Doxazosin Mesylate | 11 | $365 | $33 |
| Cephalexin | 30 | $341 | $11 |
2013: 16 drugs
| Avodart | 60 | $10,921 | $182 |
| Vesicare | 23 | $6,157 | $268 |
| Bicalutamide | 90 | $5,134 | $57 |
| Jalyn | 30 | $4,160 | $139 |
| Androgel | 11 | $4,061 | $369 |
| Tamsulosin | 174 | $3,942 | $23 |
| Cialis | 22 | $3,040 | $138 |
| Nitrofurantoin Mono-Macro | 28 | $2,719 | $97 |
| Finasteride | 53 | $2,295 | $43 |
| Estrace | 11 | $1,680 | $153 |
| Oxybutynin Chloride Er | 21 | $1,225 | $58 |
| Hydrocodone-Acetaminophen | 40 | $796 | $20 |
| Ciprofloxacin | 132 | $714 | $5 |
| Imipramine | 12 | $194 | $16 |
| Cephalexin | 12 | $78 | $6 |
| Diazepam | 17 | $52 | $3 |
Money from drug and device companies
$3,872 in 2025
| 2025 | 9 | 28 | None | $3,872 |
| 2024 | 12 | 15 | $106 | $924 |
| 2023 | 11 | 20 | None | $803 |
| 2022 | 10 | 27 | None | $1,153 |
| 2021 | 10 | 18 | None | $610 |
| 2020 | 8 | 14 | $500 | $939 |
| 2019 | 11 | 39 | None | $2,376 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Teleflex | Barrigel | $2,718 | 7 payments
|
| Medtronic | Interstim | $616 | 10 payments
|
| Valencia Technologies | Ecoin Device Kit | $150 | 3 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $130 | 1 payment
|
| Progenics Pharmaceuticals | Pylarify | $104 | 2 payments
|
| Smith+Nephew | Stravix | $70 | 2 payments
|
See all 28 published payments
| Intuitive Surgical | Meals · 2025-12-23 | Da Vinci Surgical System | $130 |
| Medtronic | Meals · 2025-12-22 | Interstim | $22 |
| Medtronic | Education · 2025-12-17 | Altaviva | $15 |
| Teleflex | Meals · 2025-12-04 | Barrigel | $109 |
| Coloplast | Meals · 2025-12-01 | Titan | $43 |
| Medtronic | Education · 2025-11-10 | Interstim | $34 |
| Smith+Nephew | Meals · 2025-11-05 | Grafix Pl | $22 |
| Medtronic | Meals · 2025-10-21 | Altaviva | $24 |
| Boston Scientific | Meals · 2025-08-21 | Watchman | $17 |
| Teleflex | Travel · 2025-05-17 | Barrigel | $1,051 |
| Teleflex | Meals · 2025-05-17 | Barrigel | $658 |
| Teleflex | Travel · 2025-05-13 | Urolift | $379 |
| Teleflex | Travel · 2025-05-13 | Urolift | $372 |
| Valencia Technologies | Meals · 2025-04-18 | Ecoin Device Kit | $25 |
| Valencia Technologies | Meals · 2025-04-18 | Ecoin Device Kit | $29 |
| Valencia Technologies | Meals · 2025-04-14 | Ecoin Device Kit | $95 |
| Medtronic | Meals · 2025-03-22 | Interstim | $231 |
| Medtronic | Meals · 2025-02-28 | Interstim | $31 |
| Teleflex | Meals · 2025-02-26 | Barrigel | $38 |
| Medtronic | Meals · 2025-02-08 | Interstim | $20 |
| Medtronic | Meals · 2025-02-08 | Interstim | $16 |
| Medtronic | Meals · 2025-02-08 | Interstim | $94 |
| Progenics Pharmaceuticals | Meals · 2025-02-08 | Pylarify | $78 |
| Medtronic | Meals · 2025-02-07 | Interstim | $130 |
| Progenics Pharmaceuticals | Meals · 2025-01-22 | Pylarify | $26 |
| Smith+Nephew | Meals · 2025-01-17 | Stravix | $48 |
| Teleflex | Meals · 2025-01-16 | Urolift | $111 |
| Sumitomo Pharma America | Meals · 2025-01-03 | Gemtesa | $23 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $924
| PROCEPT BioRobotics | Aquabeam System | $260 | 1 payment
|
| Sumitomo Pharma America | Gemtesa | $106 | 1 payment
|
| Boston Scientific | Rezum Generator | $104 | 1 payment
|
| Teleflex | None | $92 | 1 payment
|
| Progenics Pharmaceuticals | Pylarify | $89 | 1 payment
|
| Smith+Nephew | Stravix Pl | $66 | 2 payments
|
| Medtronic | Interstim | $58 | 2 payments
|
| Axonics | Axonics | $51 | 2 payments
|
| Abbvie | Botox | $34 | 1 payment
|
| KARL STORZ Endoscopy-America | None | $28 | 1 payment
|
| Coloplast | Titan | $19 | 1 payment
|
| Myriad Genetic Laboratories | Prolaris | $18 | 1 payment
|
2023: $803
| Teleflex | Urolift | $273 | 5 payments
|
| Astellas Pharma US | Myrbetriq | $130 | 3 payments
|
| KARL STORZ Endoscopy-America | Flex-X | $106 | 2 payments
|
| Progenics Pharmaceuticals | Pylarify | $85 | 1 payment
|
| UroGen Pharma | Jelmyto | $52 | 2 payments
|
| Pfizer | Xtandi | $48 | 2 payments
|
| AbbVie | Botox | $34 | 1 payment
|
| Blue Earth Diagnostics | Axumin | $27 | 1 payment
|
| Coloplast | Titan | $19 | 1 payment
|
| Axonics | Bulkamid | $17 | 1 payment
|
| Boston Scientific | Rezum Generator | $13 | 1 payment
|
2022: $1,153
| Medtronic | Interstim | $532 | 13 payments
|
| Teleflex | Urolift System | $225 | 4 payments
|
| Olympus America | Itind System | $141 | 1 payment
|
| Merck Sharp & Dohme | Lynparza | $111 | 1 payment
|
| Axonics | Axonics | $36 | 2 payments
|
| Coloplast | Titan | $29 | 1 payment
|
| Abbvie | Botox | $25 | 2 payments
|
| KARL STORZ Endoscopy-America | Image1 Connect | $24 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $18 | 1 payment
|
| Boston Scientific | Rezum Generator | $12 | 1 payment
|
2021: $610
| Medtronic | Interstim | $152 | 1 payment
|
| Intuitive Surgical | Da Vinci Surgical System | $121 | 4 payments
|
| Teleflex | Urolift System | $102 | 3 payments
|
| Cook Medical | Cook | $59 | 1 payment
|
| AbbVie | Lupron Depot | $56 | 3 payments
|
| KARL STORZ Endoscopy-America | Image 1 S | $38 | 1 payment
|
| Coloplast | Titan | $30 | 2 payments
|
| Boston Scientific | Rezum | $22 | 1 payment
|
| Pfizer | Premarin | $15 | 1 payment
|
| Myovant Sciences | Orgovyx | $15 | 1 payment
|
2020: $939
| Karl Storz Imaging | Ccu,Modular,Image1 Connect,US | $500 | 1 payment
|
| Boston Scientific | Ams | $272 | 4 payments
|
| Medtronic USA | Interstim | $81 | 4 payments
|
| Coloplast | Continence Care | $20 | 1 payment
|
| Endo Pharmaceuticals | Aveed | $18 | 1 payment
|
| Pfizer | Premarin | $17 | 1 payment
|
| NeoTract | Urolift | $16 | 1 payment
|
| Astellas Pharma US | Myrbetriq | $15 | 1 payment
|
2019: $2,376
| NeoTract | Urolift | $1,441 | 9 payments
|
| KARL STORZ Endoscopy-America | Ccu,Modular,Image1 S X-Link,US | $351 | 6 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $159 | 3 payments
|
| Boston Scientific | Ams | $118 | 2 payments
|
| AbbVie | Lupron Depot | $95 | 5 payments
|
| Medtronic USA | Interstim | $83 | 2 payments
|
| Coloplast | Restorelle | $36 | 1 payment
|
| Astellas Pharma US | Myrbetriq | $34 | 2 payments
|
| Pfizer | Toviaz | $30 | 2 payments
|
| PROCEPT BioRobotics | Aquabeam Robotic System | $15 | 1 payment
|
| Covidien LP | Endo Gia | $15 | 1 payment
|
Professional record
- NPI
- 1992796791
- Licence
- CA G73931California G73931: Current · expires 2027-12-31
- Trained
- Creighton University School of Medicine, 1990 · 36 years ago
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Urology (208800000X)
- Mailing address
- 5855 Olivas Park Dr, Ventura, CA, 93003
- NPI first listed
- 2005-10-31
- NPI last updated
- 2012-10-24
This is when the NPI record was last certified, not a medical board exam.